FBLG

FibroBiologics, Inc. Common Stock

FBLG.US fibrobiologics.com + Research + Basket
CIK 0001958777
Employees 15
Phone 281 671 5150
Fiscal year end June
IPO Jan 31, 2024
Address 455 East Medical Center Boulevard, Houston, TX, United States, 77598
0.96
-0.01 (-1.22%)
USD · NASDAQ
52-week range
0.62
9.60
Trading at 4% of the 52-week range
Market Cap
6.86M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.76
Div. Yield
N/A
% Institutions
15.25%
% Insiders
13.74%

1 Year

-87.1%

3 Year

-99.4%

10 Year

-99.4%
Description

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Actions

Add an action for FBLG.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Peter O'Heeron Founder, Chairperson & CEO 1964
Dr. Hamid Khoja Ph.D. Chief Scientific Officer 1970
Mr. Ruben A. Garcia J.D. General Counsel 1977
Mr. Jason D. Davis CPA Chief Financial Officer 1972

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 04, 2026 Hamid Khoja N/A Purchase 1.50K $7.60 $11.40K SEC
Mar 04, 2026 Pete O'heeron N/A Purchase 793.00 $7.60 $6.03K SEC
Mar 03, 2026 Pete O'heeron N/A Purchase 910.00 $8.20 $7.46K SEC
Mar 02, 2026 Jason Davis N/A Purchase 3.50K $8.20 $28.70K SEC
Mar 02, 2026 Pete O'heeron N/A Purchase 871.00 $7.00 $6.10K SEC
Feb 27, 2026 Ruben A Garcia N/A Purchase 2.00K $6.60 $13.20K SEC
Dec 11, 2025 Ruben A Garcia N/A Purchase 7.00K $6.80 $47.60K SEC
May 27, 2025 Hamid Khoja N/A Purchase 1.00K $16.80 $16.80K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Fund Evaluation Group, LLC 51.79K Jun 30, 2026 0.73% $0.00 0.00%
Geode Capital Management, LLC 30.30K Jun 30, 2026 0.43% $0.00 2.33%
Vanguard Capital Management, LLC 27.77K Jun 30, 2026 0.39% $0.00 -58.96%
Qube Research & Technologies 24.31K Jun 30, 2026 0.34% $0.00 0.00%
BlackRock Inc 18.24K Jun 30, 2026 0.26% $0.00 -26.00%
Barclays PLC 7.24K Jun 30, 2026 0.10% $0.00 0.00%
Vanguard Fiduciary Trust Co 6.38K Jun 30, 2026 0.09% $0.00 0.00%
Tower Research Capital LLC 4.73K Jun 30, 2026 0.07% $0.00 927.83%
Advisor Group Holdings, Inc. 2.40K Jun 30, 2026 0.03% $0.00 1,461.04%
Royal Bank of Canada 1.52K Jun 30, 2026 0.02% $0.00 0.00%
UBS Group AG 1.07K Jun 30, 2026 0.02% $0.00 -81.24%
Islay Capital Management, LLC 169.00 Jun 30, 2026 0.00% $0.00 0.00%
Coconut Grove Bank 100.00 Jun 30, 2026 0.00% $0.00 0.00%
BNP Paribas Arbitrage, SA 64.00 Jun 30, 2026 0.00% $0.00 -3.03%
Hanson Mcclain Inc 13.00 Jun 30, 2026 0.00% $0.00 0.00%
Vanguard Global Advisers, LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Wells Fargo & Co 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Goss Wealth Management LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Renaissance Technologies Corp 0.00 Jun 30, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 T. Rowe Price M-A Glb Inc I USD 280.00K 3.95% ▲ 0.00% Sep 30, 2026
2 Fidelity Extended Market Index 24.25K 0.34% ▼ 0.53% Aug 31, 2026
3 Fidelity Series Total Market Index 2.57K 0.04% ▲ 0.00% Aug 31, 2026
4 Fidelity Total Market Index 2.27K 0.03% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $6.86M
EBITDA: $-16.47M
Book Value: $0.76
Earnings/Share: $-4.95
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -95.77%
ROE (TTM): -660.08%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $4.89M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 7.08M
Shares Float: 5.19M
% Insiders: 13.74%
% Institutions: 15.25%
Shares Short: 330.55K
Shares Short (Prior Month): 522.11K
Short Ratio: 2.32
Short % Float: 4.89%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-832.00K
Gross Profit
subtotal
$-832.00K
SG&A
adjust
$-9.24M
R&D
adjust
$-7.41M
Operating Income
subtotal
$-16.65M
Other / Non-Operating Items
adjust
$-2.00M
Net Income
subtotal
$-18.65M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about FBLG.US!